REKRYTERING AV NY VD - Oblique

Search
News
Press releases
Contact
Work with us

About us
Technology
- Abiprot® Antibody Discovery Platform
- Scientific publications
Portfolio
- Pipeline
- Programs
Corporate Governance
Investor Relations
Partnering
- Partnership & Collaboration

REKRYTERING AV NY VD

REKRYTERING AV NY VD

To read more about this news, click on the link below

Rekrytering av ny VD 28th July 2022

Contact

Oblique Therapeutics AB (publ)info@obliquet.com

Gothenburg

413 46 Göteborg

Arvid Wallgrens Backe 20

Sweden

Stockholm

113 52 Stockholm

Döbelnsgatan 64

Sweden

Menu

Vision
About us
R&D
Portfolio
Corporate Governance
Investor Relations
Privacy Policy
Disclaimer
Contact

About

Oblique Therapeutics AB (publ) is a Swedish biotech company developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain, and advanced cancer. The company uses Abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome.

Follow us on LinkedIn

Copyright © 2021 Oblique Therapeutics AB (publ)